Centene (CNC) Competitors $62.19 -0.68 (-1.09%) Closing price 01/17/2025 03:59 PM EasternExtended Trading$62.44 +0.25 (+0.40%) As of 08:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CNC vs. ELV, CI, HUM, MOH, UNH, OSCR, ALHC, CLOV, TRUP, and NEUEShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), The Cigna Group (CI), Humana (HUM), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Clover Health Investments (CLOV), Trupanion (TRUP), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry. Centene vs. Elevance Health The Cigna Group Humana Molina Healthcare UnitedHealth Group Oscar Health Alignment Healthcare Clover Health Investments Trupanion NeueHealth Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, community ranking, risk, analyst recommendations, institutional ownership, valuation and earnings. Do analysts rate ELV or CNC? Elevance Health presently has a consensus target price of $536.53, indicating a potential upside of 39.63%. Centene has a consensus target price of $80.92, indicating a potential upside of 30.13%. Given Elevance Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Elevance Health is more favorable than Centene.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elevance Health 1 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.81Centene 1 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.57 Does the media refer more to ELV or CNC? In the previous week, Elevance Health had 30 more articles in the media than Centene. MarketBeat recorded 44 mentions for Elevance Health and 14 mentions for Centene. Elevance Health's average media sentiment score of 1.32 beat Centene's score of 0.89 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 33 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Centene 9 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, ELV or CNC? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElevance Health$171.34B0.52$5.99B$27.4314.01Centene$154.00B0.20$2.70B$5.7610.80 Is ELV or CNC more profitable? Elevance Health has a net margin of 3.68% compared to Centene's net margin of 1.90%. Elevance Health's return on equity of 19.56% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Elevance Health3.68% 19.56% 7.22% Centene 1.90%13.32%4.32% Which has more risk & volatility, ELV or CNC? Elevance Health has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, Centene has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500. Do institutionals and insiders believe in ELV or CNC? 89.2% of Elevance Health shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.3% of Elevance Health shares are held by insiders. Comparatively, 0.3% of Centene shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor ELV or CNC? Centene received 184 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 73.41% of users gave Centene an outperform vote while only 67.26% of users gave Elevance Health an outperform vote. CompanyUnderperformOutperformElevance HealthOutperform Votes86567.26% Underperform Votes42132.74% CenteneOutperform Votes104973.41% Underperform Votes38026.59% SummaryElevance Health beats Centene on 15 of the 18 factors compared between the two stocks. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneHospital & medical service plans IndustryMedical SectorNYSE ExchangeMarket Cap$31.40B$60.83B$5.33B$19.88BDividend YieldN/A1.65%5.36%3.65%P/E Ratio10.8013.7962.9736.01Price / Sales0.200.681,268.8116.96Price / Cash6.698.5644.4820.10Price / Book1.285.154.885.78Net Income$2.70B$2.38B$117.85M$997.97M7 Day Performance-1.98%1.90%1.44%2.23%1 Month Performance4.37%23.84%2.50%4.72%1 Year Performance-16.13%39.80%25.75%18.80% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.9882 of 5 stars$62.19-1.1%$80.92+30.1%-16.1%$31.43B$154.00B10.8067,700ELVElevance Health4.3939 of 5 stars$396.94+4.1%$536.53+35.2%-17.3%$92.06B$174.02B14.47104,900Upcoming EarningsShort Interest ↑News CoveragePositive NewsCIThe Cigna Group4.9951 of 5 stars$281.03+0.7%$395.93+40.9%-5.9%$78.17B$229.75B26.5172,500Positive NewsHUMHumana4.49 of 5 stars$288.90+7.4%$302.00+4.5%-29.6%$34.79B$115.01B25.5967,100MOHMolina Healthcare4.9798 of 5 stars$294.67+3.0%$359.18+21.9%-21.7%$16.86B$39.20B14.9715,000Positive NewsUNHUnitedHealth Group4.9554 of 5 stars$543.76+4.4%$626.79+15.3%+1.3%$500.41B$389.07B35.42400,000Earnings ReportAnalyst RevisionOSCROscar Health3.738 of 5 stars$14.25+0.5%$21.56+51.3%+48.4%$3.52B$8.22B-237.462,710ALHCAlignment Healthcare0.779 of 5 stars$13.22+11.3%$11.38-14.0%+105.4%$2.53B$2.47B-17.17850CLOVClover Health Investments1.7434 of 5 stars$3.77+3.6%$5.00+32.6%+335.2%$1.89B$2.12B-18.85680Short Interest ↑News CoverageGap UpTRUPTrupanion1.7649 of 5 stars$42.94-2.3%$45.33+5.6%+73.6%$1.82B$1.24B-134.191,142Gap UpNEUENeueHealth1.0793 of 5 stars$7.33flat$7.00-4.5%N/A$60.73M$996.89M-0.141,252 Related Companies and Tools Related Companies ELV Alternatives CI Alternatives HUM Alternatives MOH Alternatives UNH Alternatives OSCR Alternatives ALHC Alternatives CLOV Alternatives TRUP Alternatives NEUE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CNC) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.